Prelude Capital Management’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $213K | Sell |
15,203
-7,882
| -34% | -$111K | 0.02% | 783 |
|
|
2025
Q1 | $361K | Buy |
+23,085
| New | +$361K | 0.03% | 546 |
|
|
2024
Q4 | – | Sell |
-12,714
| Closed | -$118K | – | 1083 |
|
|
2024
Q3 | $118K | Buy |
+12,714
| New | +$118K | 0.01% | 1038 |
|
|
2023
Q2 | – | Sell |
-14,648
| Closed | -$161K | – | 1000 |
|
|
2023
Q1 | $161K | Buy |
+14,648
| New | +$161K | 0.01% | 807 |
|